Status and phase
Conditions
Treatments
About
It is a randomized phase II clinical study, unicentre aimed to evaluate the tolerability, safety and efficacy of 18-Methoxyoronaridine as a candidate of tegumentary leishmaniasis treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
52 participants in 7 patient groups
Loading...
Central trial contact
Jan Carlo Delorenzi, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal